IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

News

02/03/2017 - Institutional news

Chemotargets, one of the five top Biotechs at BIO Europe Spring 2017

From 20th to 22nd March, Barcelona will host the most important European partnering conference in the biotech and pharma sectors. The aim of this International Conference is to bring together pharmaceutical, biotechnology and financial firms to form alliances and partnerships for achieving common goals. More than 1,400 companies from 45 countries are expected to participate, with more than 2,400 people attending.

In this edition, Chemotargets, the IMIM spin-off dedicated to developing software for predicting the mechanism of action and safety of new drugs, directed by Dr. Jordi Mestres, Coordinator of the Systems Pharmacology research group at the GRIB (IMIM-UPF), is one of the 5 biotech companies from Barcelona invited to take part.

In Labiotech.eu, one of the leading digital media channels covering European Biotech news, presented this handful of local companies in its article "Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017", highlighting some of them for their innovative diagnostic and therapy-related technology. 

More news

Contact

Head of Communications:
Rosa Manaut

Communications office:
Marta Calsina(ELIMINAR)

Tel:
(+34) 93 316 06 80
(+34) 699 094 833

Doctor Aiguader, 88
08003 Barcelona

© Institut Hospital del Mar d'Investigacions Mèdiques Legal Note | Cookie Policy | Site Index | Accessibility | Find Us | Contact